November put buying suggests further drop. The November 15th $8 put options on Teva Pharmaceutical (TEVA) saw over 17,000 contracts trade against a prior open interest of 243, indicating a 70-fold surge in volume on the trade. With shares of Teva around $7, the $8 puts are already $1 in-the-money and should move penny-for-penny with […]